Evidence map›Paper›PMID 41017930›Full record

ArticleFood chemistry: X2025

Guava (

Eman Butt, Ammar B Altemimi, Aqsa Younas, Masood Sadiq Butt, Maryam Jalal, Maham Bhatty, Gholamreza Abdi, Rana Muhammad Aadil

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Food chemistry: X, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Editorial Special issue:Food chemistry: X · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Eman ButtNational Institute of Food Science and Technology, University of Agriculture, Faisalabad 38000, Pakistan.
Ammar B AltemimiFood Science Department, College of Agriculture, University of Basrah, Basrah 61004, Iraq.
Aqsa YounasNational Institute of Food Science and Technology, University of Agriculture, Faisalabad 38000, Pakistan.
Masood Sadiq ButtCollege of Human Nutrition & Dietetics, Ziauddin University, Karachi, Pakistan.
Maryam JalalNational Institute of Food Science and Technology, University of Agriculture, Faisalabad 38000, Pakistan.
Maham BhattyNational Institute of Food Science and Technology, University of Agriculture, Faisalabad 38000, Pakistan.
Gholamreza AbdiDepartment of Biotechnology, Persian Gulf Research Institute, Persian Gulf University, Bushehr, 75169, Iran.
Rana Muhammad AadilNational Institute of Food Science and Technology, University of Agriculture, Faisalabad 38000, Pakistan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The guava ( Objective: The goal of this review is to compile the most recent information on the pharmacological properties of guava, with an emphasis on its anti-inflammatory, anti-hypertensive, anti-obesity, antioxidant, antidiarrheal and antidiabetic properties as well as on its ability to treat dental diseases and increase haemoglobin levels in body. Methods: To assess the potential health benefits derived from guava, a thorough review of it in vitro, and Results: The main cause of guava's strong bioactivity is its flavonoids. Its application in the treatment of different diseases is supported by evidence. The medicinal potential of its inclusion in functional meals is encouraging. Conclusion: The guava fruit has a wide range of therapeutic properties and is rich in nutrients. More human trials are needed to confirm efficacy, optimize dosage, and guarantee safety in long-term usage, even though preclinical research appears encouraging.

Indexed as

Bioactive substancesFunctional foodsGuavaMedicinal qualitiesPsidium guajava

Identifiers

PMID41017930
PMCPMC12466288

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.